Humanoid (HERB) Stock Price
Humanoid Price
Revenue at Humanoid has contracted by 17.1% per year over the past 18 years to 18.59 M USD. Earnings per share have declined at 11.7% per year over the last 18 years. For Humanoid, the net margin of 28.6% is up versus 13.5% a few years ago. The stock trades about 25% above its 52-week low.
Humanoid stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Humanoid over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Humanoid stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Humanoid's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Humanoid Price |
|---|---|
| 7/20/2026 | 0.02 USD |
| 7/17/2026 | 0.02 USD |
| 7/16/2026 | 0.02 USD |
| 7/15/2026 | 0.02 USD |
| 7/14/2026 | 0.04 USD |
| 7/13/2026 | 0.04 USD |
| 7/10/2026 | 0.04 USD |
| 7/9/2026 | 0.02 USD |
| 7/8/2026 | 0.02 USD |
| 7/7/2026 | 0.02 USD |
| 7/6/2026 | 0.02 USD |
| 7/2/2026 | 0.02 USD |
| 7/1/2026 | 0.03 USD |
| 6/30/2026 | 0.03 USD |
| 6/29/2026 | 0.03 USD |
| 6/26/2026 | 0.03 USD |
| 6/25/2026 | 0.03 USD |
| 6/24/2026 | 0.03 USD |
| 6/23/2026 | 0.03 USD |
| 6/22/2026 | 0.03 USD |
| 6/18/2026 | 0.03 USD |
| 6/17/2026 | 0.03 USD |
| 6/16/2026 | 0.03 USD |
| 6/15/2026 | 0.04 USD |
| 6/12/2026 | 0.03 USD |
| 6/11/2026 | 0.03 USD |
| 6/10/2026 | 0.03 USD |
| 6/9/2026 | 0.03 USD |
| 6/8/2026 | 0.03 USD |
| 6/5/2026 | 0.03 USD |
| 6/4/2026 | 0.03 USD |
| 6/3/2026 | 0.04 USD |
| 6/2/2026 | 0.04 USD |
| 6/1/2026 | 0.04 USD |
| 5/29/2026 | 0.04 USD |
| 5/28/2026 | 0.03 USD |
| 5/27/2026 | 0.03 USD |
| 5/26/2026 | 0.03 USD |
| 5/22/2026 | 0.03 USD |
| 5/21/2026 | 0.03 USD |
| 5/20/2026 | 0.03 USD |
| 5/19/2026 | 0.03 USD |
| 5/18/2026 | 0.04 USD |
| 5/15/2026 | 0.04 USD |
| 5/14/2026 | 0.03 USD |
| 5/13/2026 | 0.04 USD |
| 5/12/2026 | 0.04 USD |
| 5/11/2026 | 0.04 USD |
| 5/10/2026 | 0.04 USD |
| 5/6/2026 | 0.03 USD |
| 5/5/2026 | 0.04 USD |
| 5/4/2026 | 0.05 USD |
| 5/1/2026 | 0.03 USD |
| 4/30/2026 | 0.04 USD |
| 4/29/2026 | 0.03 USD |
| 4/28/2026 | 0.02 USD |
| 4/27/2026 | 0.02 USD |
| 4/24/2026 | 0.02 USD |
| 4/23/2026 | 0.04 USD |
| 4/22/2026 | 0.04 USD |
| 4/21/2026 | 0.02 USD |
| 4/20/2026 | 0.02 USD |
| 4/17/2026 | 0.02 USD |
| 4/16/2026 | 0.02 USD |
| 4/15/2026 | 0.02 USD |
| 4/14/2026 | 0.02 USD |
| 4/13/2026 | 0.02 USD |
| 4/10/2026 | 0.02 USD |
| 4/9/2026 | 0.02 USD |
| 4/8/2026 | 0.02 USD |
| 4/7/2026 | 0.02 USD |
| 4/6/2026 | 0.02 USD |
| 4/2/2026 | 0.02 USD |
| 4/1/2026 | 0.02 USD |
| 3/31/2026 | 0.02 USD |
| 3/30/2026 | 0.02 USD |
| 3/27/2026 | 0.02 USD |
| 3/26/2026 | 0.02 USD |
| 3/25/2026 | 0.02 USD |
| 3/24/2026 | 0.02 USD |
| 3/23/2026 | 0.02 USD |
| 3/20/2026 | 0.02 USD |
| 3/19/2026 | 0.02 USD |
| 3/18/2026 | 0.02 USD |
| 3/17/2026 | 0.02 USD |
| 3/16/2026 | 0.02 USD |
| 3/13/2026 | 0.02 USD |
| 3/12/2026 | 0.02 USD |
| 3/11/2026 | 0.02 USD |
| 3/10/2026 | 0.02 USD |
| 3/9/2026 | 0.03 USD |
| 3/6/2026 | 0.03 USD |
| 3/5/2026 | 0.03 USD |
| 3/4/2026 | 0.03 USD |
| 3/3/2026 | 0.03 USD |
| 3/2/2026 | 0.03 USD |
| 2/27/2026 | 0.04 USD |
| 2/26/2026 | 0.04 USD |
| 2/25/2026 | 0.04 USD |
| 2/24/2026 | 0.03 USD |
| 2/23/2026 | 0.03 USD |
| 2/20/2026 | 0.05 USD |
| 2/19/2026 | 0.04 USD |
| 2/18/2026 | 0.04 USD |
| 2/17/2026 | 0.04 USD |
| 2/13/2026 | 0.05 USD |
| 2/12/2026 | 0.02 USD |
| 2/11/2026 | 0.02 USD |
| 2/10/2026 | 0.02 USD |
| 2/9/2026 | 0.02 USD |
| 2/6/2026 | 0.04 USD |
| 2/5/2026 | 0.03 USD |
| 2/4/2026 | 0.03 USD |
| 2/3/2026 | 0.04 USD |
| 2/2/2026 | 0.04 USD |
| 1/30/2026 | 0.04 USD |
| 1/29/2026 | 0.04 USD |
| 1/28/2026 | 0.03 USD |
| 1/27/2026 | 0.04 USD |
| 1/26/2026 | 0.05 USD |
| 1/23/2026 | 0.05 USD |
| 1/22/2026 | 0.05 USD |
| 1/21/2026 | 0.05 USD |
| 1/20/2026 | 0.05 USD |
| 1/16/2026 | 0.05 USD |
| 1/15/2026 | 0.03 USD |
| 1/14/2026 | 0.03 USD |
| 1/13/2026 | 0.05 USD |
| 1/12/2026 | 0.03 USD |
| 1/9/2026 | 0.05 USD |
| 1/8/2026 | 0.05 USD |
| 1/7/2026 | 0.03 USD |
| 1/6/2026 | 0.03 USD |
| 1/5/2026 | 0.05 USD |
| 1/2/2026 | 0.05 USD |
| 12/31/2025 | 0.05 USD |
| 12/30/2025 | 0.05 USD |
| 12/29/2025 | 0.03 USD |
| 12/26/2025 | 0.03 USD |
| 12/24/2025 | 0.03 USD |
| 12/23/2025 | 0.02 USD |
| 12/22/2025 | 0.02 USD |
| 12/19/2025 | 0.02 USD |
| 12/18/2025 | 0.02 USD |
| 12/17/2025 | 0.02 USD |
| 12/16/2025 | 0.02 USD |
| 12/15/2025 | 0.03 USD |
| 12/12/2025 | 0.05 USD |
| 12/11/2025 | 0.03 USD |
| 12/10/2025 | 0.03 USD |
| 12/9/2025 | 0.03 USD |
| 12/8/2025 | 0.03 USD |
| 12/5/2025 | 0.03 USD |
| 12/4/2025 | 0.03 USD |
| 12/3/2025 | 0.05 USD |
| 12/2/2025 | 0.05 USD |
| 12/1/2025 | 0.05 USD |
| 11/28/2025 | 0.05 USD |
| 11/26/2025 | 0.05 USD |
| 11/25/2025 | 0.05 USD |
| 11/24/2025 | 0.03 USD |
| 11/21/2025 | 0.03 USD |
| 11/20/2025 | 0.04 USD |
| 11/19/2025 | 0.04 USD |
| 11/18/2025 | 0.04 USD |
| 11/17/2025 | 0.04 USD |
| 11/14/2025 | 0.04 USD |
| 11/13/2025 | 0.04 USD |
| 11/12/2025 | 0.04 USD |
| 11/11/2025 | 0.04 USD |
| 11/10/2025 | 0.04 USD |
| 11/7/2025 | 0.03 USD |
| 11/6/2025 | 0.04 USD |
| 11/5/2025 | 0.04 USD |
| 11/4/2025 | 0.03 USD |
| 11/3/2025 | 0.05 USD |
| 10/31/2025 | 0.03 USD |
| 10/30/2025 | 0.03 USD |
| 10/29/2025 | 0.04 USD |
| 10/28/2025 | 0.05 USD |
| 10/27/2025 | 0.04 USD |
| 10/24/2025 | 0.04 USD |
| 10/23/2025 | 0.04 USD |
| 10/22/2025 | 0.04 USD |
| 10/21/2025 | 0.04 USD |
| 10/20/2025 | 0.04 USD |
| 10/17/2025 | 0.04 USD |
| 10/16/2025 | 0.04 USD |
| 10/15/2025 | 0.04 USD |
| 10/14/2025 | 0.05 USD |
| 10/13/2025 | 0.05 USD |
| 10/10/2025 | 0.05 USD |
| 10/9/2025 | 0.04 USD |
| 10/8/2025 | 0.04 USD |
| 10/7/2025 | 0.04 USD |
| 10/6/2025 | 0.04 USD |
| 10/3/2025 | 0.03 USD |
| 10/2/2025 | 0.05 USD |
| 10/1/2025 | 0.05 USD |
| 9/30/2025 | 0.05 USD |
| 9/29/2025 | 0.05 USD |
| 9/26/2025 | 0.05 USD |
| 9/25/2025 | 0.05 USD |
| 9/24/2025 | 0.03 USD |
| 9/23/2025 | 0.05 USD |
| 9/22/2025 | 0.05 USD |
| 9/19/2025 | 0.05 USD |
| 9/18/2025 | 0.05 USD |
| 9/17/2025 | 0.05 USD |
| 9/16/2025 | 0.05 USD |
| 9/15/2025 | 0.03 USD |
| 9/12/2025 | 0.04 USD |
| 9/11/2025 | 0.05 USD |
| 9/10/2025 | 0.03 USD |
| 9/9/2025 | 0.03 USD |
| 9/8/2025 | 0.03 USD |
| 9/5/2025 | 0.03 USD |
| 9/4/2025 | 0.03 USD |
| 9/3/2025 | 0.03 USD |
| 9/2/2025 | 0.02 USD |
| 8/29/2025 | 0.03 USD |
| 8/28/2025 | 0.03 USD |
| 8/27/2025 | 0.03 USD |
| 8/26/2025 | 0.03 USD |
| 8/25/2025 | 0.03 USD |
| 8/22/2025 | 0.03 USD |
| 8/21/2025 | 0.03 USD |
| 8/20/2025 | 0.03 USD |
| 8/19/2025 | 0.03 USD |
| 8/18/2025 | 0.03 USD |
| 8/15/2025 | 0.03 USD |
| 8/14/2025 | 0.03 USD |
| 8/13/2025 | 0.03 USD |
| 8/12/2025 | 0.03 USD |
| 8/11/2025 | 0.03 USD |
| 8/8/2025 | 0.04 USD |
| 8/7/2025 | 0.03 USD |
| 8/6/2025 | 0.03 USD |
| 8/5/2025 | 0.03 USD |
| 8/4/2025 | 0.03 USD |
| 8/1/2025 | 0.03 USD |
| 7/31/2025 | 0.04 USD |
| 7/30/2025 | 0.03 USD |
| 7/29/2025 | 0.04 USD |
| 7/28/2025 | 0.06 USD |
| 7/25/2025 | 0.05 USD |
| 7/24/2025 | 0.05 USD |
| 7/23/2025 | 0.05 USD |
| 7/22/2025 | 0.05 USD |
Humanoid Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Humanoid Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.54 | 0.57 | 0.60 | 0.66 | 0.74 | 0.74 | 0.85 | 0.95 | 0.99 | 1.01 | 1.01 | 0.94 | 0.01 | 0.01 | 0.02 |
| – | 4.81 | 6.17 | 8.80 | 12.37 | 0.41 | 14.88 | 11.78 | 4.64 | 1.81 | 0.10 | -7.31 | -98.72 | 16.67 | 28.57 |
| 10.35 | 11.46 | 11.63 | 11.60 | 11.01 | 11.37 | 12.37 | 12.75 | 13.39 | 14.14 | 14.03 | 12.69 | 25.00 | 28.57 | 27.78 |
| 56.00 | 65.00 | 70.00 | 76.00 | 81.00 | 84.00 | 105.00 | 121.00 | 133.00 | 143.00 | 142.00 | 119.00 | 3.00 | 4.00 | 5.00 |
| 54.00 | 63.00 | 67.00 | 72.00 | 75.00 | 78.00 | 99.00 | 115.00 | 126.00 | 136.00 | 136.00 | 113.00 | 2.00 | 3.00 | 4.00 |
| 9.98 | 11.11 | 11.13 | 10.99 | 10.19 | 10.55 | 11.66 | 12.12 | 12.69 | 13.45 | 13.44 | 12.05 | 16.67 | 21.43 | 22.22 |
| 49.00 | 61.00 | 66.00 | 71.00 | 74.00 | 77.00 | 97.00 | 114.00 | 126.00 | 136.00 | 136.00 | 111.00 | 2.00 | 3.00 | 5.00 |
| – | 24.49 | 8.20 | 7.58 | 4.23 | 4.05 | 25.97 | 17.53 | 10.53 | 7.94 | – | -18.38 | -98.20 | 50.00 | 66.67 |
| 155.10 | 155.10 | 155.10 | 155.10 | 155.10 | 155.10 | 155.10 | 155.10 | 155.10 | 155.10 | 155.10 | 157.17 | 157.17 | 157.17 | 157.17 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Humanoid generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Humanoid retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Humanoid's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Humanoid has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Humanoid's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Humanoid stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Humanoid Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Humanoid business model & stock analysis
Humanoid SWOT Analysis
Strengths
Yasheng Group possesses several strengths that contribute to its success and competitive advantage. The key strengths are as follows:
- Strong Market Position: Yasheng Group has established itself as a leading player in its industry, commanding a significant market share.
- Diverse Product Portfolio: The company offers a wide range of products, catering to diverse customer needs and reducing dependency on any single product line.
- Financial Stability: Yasheng Group has a strong financial position, with steady revenue growth and healthy profitability ratios.
- Global Presence: The company has successfully expanded its operations internationally, enabling it to leverage opportunities in multiple markets.
Weaknesses
Despite its overall strengths, Yasheng Group also faces certain weaknesses that pose challenges to its growth and sustainability:
- Dependence on Key Markets: The company heavily relies on a few key markets for a significant portion of its sales revenue, making it vulnerable to fluctuations in these markets.
- Limited Brand Recognition: Yasheng Group's brand awareness is relatively low compared to some of its competitors, which may limit its ability to attract new customers.
- Operational Complexity: As a result of its diversified product portfolio and global operations, the company may face challenges in effectively managing its complex operations.
Opportunities
Yasheng Group can capitalize on the following opportunities to enhance its future prospects:
- Emerging Markets: Expansion into emerging markets presents significant growth potential for Yasheng Group, allowing it to tap into new customer segments and diversify its revenue sources.
- Technological Advancements: Leveraging technological advancements can help the company improve operational efficiency, develop innovative products, and strengthen its competitive position.
- Strategic Partnerships: Collaborating with strategic partners, such as suppliers, distributors, or complementary businesses, can enable Yasheng Group to access new markets and resources.
Threats
Yasheng Group faces certain external threats that may hinder its growth and profitability:
- Intense Competition: The industry Yasheng Group operates in is highly competitive, with numerous players vying for market share, which may exert pricing pressure and erode profitability.
- Regulatory Challenges: Increasing regulations and compliance requirements in the industry can pose challenges in terms of additional costs, legal complexities, and potential reputational risks.
- Economic Volatility: Global economic fluctuations and uncertainties can impact consumer spending patterns, demand for Yasheng Group's products, and overall business performance.
Humanoid Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Humanoid historical P/E ratio, EBIT multiple, and P/S ratio
Humanoid annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Humanoid shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Humanoid Executives and Management Board
Mr. Haiyun Zhuang
(46)Chief Financial Officer, Treasurer, Secretary, Director · since 2004
Dr. Yong Li
(61)Chairman of the Board · since 2017
Mr. Wei Hao Cui
(44)President, Chief Executive Officer · since 2016
Mr. Robert Cardinal
(65)Senior Financial Officer
Mr. Darong Liu
(47)Chief Operating Officer, Director · since 2010
Frequently asked questions about Humanoid
Yasheng Group operates within the agriculture and food processing industries. The company's business model primarily focuses on cultivating, processing, and distributing various agricultural products. Yasheng Group engages in activities such as the production of field crops, vegetables, fruits, and nuts. Furthermore, the company also involves itself in livestock breeding and aquatic farming. By employing advanced technologies and sustainable practices, Yasheng Group strives to ensure the high quality and safety of its products. Through its vertically integrated supply chain, the company aims to provide customers with a diverse range of nutritious and premium agricultural products.
Humanoid stock
Humanoid Peer Group
Humanoid Ticker
Humanoid FIGI
All fundamentals and in-depth analysis of Humanoid
Our stock analysis for Humanoid stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humanoid. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.